CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
153.35
1.51%
Market Trading Hours* (UTC) Opens on Wednesday at 08:00

Mon - Fri: 08:00 - 16:30

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading сonditions
Spread 0.60
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.022099 %
Charges from full value of position ($-4.20)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.022099%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.000123 %
Charges from full value of position ($-0.02)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.000123%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency EUR
Margin 5%
Stock exchange Germany
Commission on trade 0%

*Information provided by Capital.com

Merck KGaA ESG Risk Ratings

High Medium Low Negligible

‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly

More ESG coverage

Key Stats
Prev. Close* 155.7
Open* 155.4
1-Year Change* -14.99%
Day's Range* 153.35 - 155.5
52 wk Range 134.30-195.75
Average Volume (10 days) 307.91K
Average Volume (3 months) 7.85M
Market Cap 18.96B
P/E Ratio 22.03
Shares Outstanding 434.78M
Revenue 21.43B
EPS 6.66
Dividend (Yield %) 1.49966
Beta 0.60
Next Earnings Date Mar 7, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 20, 2024 153.35 -2.25 -1.45% 155.60 155.70 153.30
Feb 19, 2024 155.70 1.85 1.20% 153.85 156.10 153.50
Feb 16, 2024 156.00 0.25 0.16% 155.75 156.95 154.65
Feb 15, 2024 155.35 0.85 0.55% 154.50 156.20 154.10
Feb 14, 2024 153.45 3.30 2.20% 150.15 154.20 149.90
Feb 13, 2024 151.05 -0.40 -0.26% 151.45 152.75 150.35
Feb 12, 2024 152.10 -0.65 -0.43% 152.75 153.30 151.30
Feb 9, 2024 152.05 0.95 0.63% 151.10 152.85 150.65
Feb 8, 2024 150.30 1.75 1.18% 148.55 152.90 148.55
Feb 7, 2024 149.15 -1.90 -1.26% 151.05 151.55 149.00
Feb 6, 2024 150.05 1.85 1.25% 148.20 150.05 146.15
Feb 5, 2024 148.00 1.50 1.02% 146.50 149.15 146.50
Feb 2, 2024 147.30 -3.05 -2.03% 150.35 150.80 146.40
Feb 1, 2024 149.35 -0.85 -0.57% 150.20 151.35 149.15
Jan 31, 2024 151.75 0.85 0.56% 150.90 153.70 150.90
Jan 30, 2024 151.20 -0.45 -0.30% 151.65 154.00 147.80
Jan 29, 2024 153.60 0.10 0.07% 153.50 154.95 151.95
Jan 26, 2024 155.45 2.45 1.60% 153.00 156.80 152.25
Jan 25, 2024 147.10 0.60 0.41% 146.50 147.10 144.60
Jan 24, 2024 147.20 -1.20 -0.81% 148.40 149.25 147.00

Merck KGaA - EUR Events

Time (UTC) Country Event
Thursday, March 7, 2024

Time (UTC)

06:00

Country

DE

Event

Q4 2023 Merck KGaA Earnings Release
Q4 2023 Merck KGaA Earnings Release

Forecast

-

Previous

-

Time (UTC)

09:00

Country

DE

Event

Q4 2023 Merck KGaA Earnings Press Conference
Q4 2023 Merck KGaA Earnings Press Conference

Forecast

-

Previous

-

Time (UTC)

13:00

Country

DE

Event

Q4 2023 Merck KGaA Earnings Call
Q4 2023 Merck KGaA Earnings Call

Forecast

-

Previous

-
Friday, April 26, 2024

Time (UTC)

10:59

Country

DE

Event

Merck KGaA Annual Shareholders Meeting
Merck KGaA Annual Shareholders Meeting

Forecast

-

Previous

-
Wednesday, May 15, 2024

Time (UTC)

05:00

Country

DE

Event

Q1 2024 Merck KGaA Earnings Release
Q1 2024 Merck KGaA Earnings Release

Forecast

-

Previous

-

Time (UTC)

08:00

Country

DE

Event

Q1 2024 Merck KGaA Earnings Press Conference
Q1 2024 Merck KGaA Earnings Press Conference

Forecast

-

Previous

-

Time (UTC)

12:00

Country

DE

Event

Q1 2024 Merck KGaA Earnings Call
Q1 2024 Merck KGaA Earnings Call

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 22232 19687 17534 16152 14836
Revenue 22232 19687 17534 16152 14836
Cost of Revenue, Total 8413 7325 6782 5951 5342
Gross Profit 13819 12362 10752 10201 9494
Total Operating Expense 17758 15508 14549 14032 13109
Selling/General/Admin. Expenses, Total 5257 4855 4600 4686 4256
Research & Development 2446 2400 2262 2239 2220
Depreciation / Amortization 616 589 636 923 979
Interest Expense (Income) - Net Operating 154 1 62
Unusual Expense (Income) 627 184 85 389 339
Other Operating Expenses, Total 245 154 184 -156 -89
Operating Income 4474 4179 2985 2120 1727
Interest Income (Expense), Net Non-Operating -153 -255 -350 -338 -209
Other, Net -34 0 -5 -47 -57
Net Income Before Taxes 4287 3924 2630 1735 1461
Net Income After Taxes 3339 3065 1993 1295 1093
Minority Interest -14 -10 -7 -3 -22
Net Income Before Extra. Items 3325 3055 1986 1292 1071
Total Extraordinary Items 0 28 2303
Net Income 3325 3055 1986 1320 3374
Income Available to Common Excl. Extra. Items 3326 3055 1987 1292 1071
Income Available to Common Incl. Extra. Items 3326 3055 1987 1320 3374
Diluted Net Income 3326 3055 1987 1320 3374
Diluted Weighted Average Shares 434.778 434.566 434.792 434.211 434.794
Diluted EPS Excluding Extraordinary Items 7.64988 7.03 4.57 2.97552 2.46324
Dividends per Share - Common Stock Primary Issue 2.2 1.85 1.4 1.3 1.25
Diluted Normalized EPS 8.7731 7.36072 4.71815 3.6442 3.04653
Total Adjustments to Net Income 1 1 0
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 5302 5293 5660 5806 5568
Revenue 5302 5293 5660 5806 5568
Cost of Revenue, Total 2139 1973 2284 2147 2109
Gross Profit 3163 3320 3376 3659 3459
Total Operating Expense 4333 4258 4771 4572 4391
Selling/General/Admin. Expenses, Total 1484 1467 1570 1551 1525
Research & Development 600 597 694 642 600
Unusual Expense (Income) 10 2 -1 -6 9
Other Operating Expenses, Total 100 219 224 238 148
Operating Income 969 1035 889 1234 1177
Interest Income (Expense), Net Non-Operating -76 -23 -51 -47 -56
Other, Net 1 1 1
Net Income Before Taxes 894 1012 839 1187 1122
Net Income After Taxes 706 799 659 926 870
Minority Interest -3 -4 -5 -3 -3
Net Income Before Extra. Items 703 795 654 923 867
Net Income 703 795 654 923 867
Income Available to Common Excl. Extra. Items 704 796 655 923 867
Income Available to Common Incl. Extra. Items 704 796 655 923 867
Diluted Net Income 704 796 655 923 867
Diluted Weighted Average Shares 434.568 434.973 434.063 435.377 435.678
Diluted EPS Excluding Extraordinary Items 1.62 1.83 1.509 2.12 1.99
Dividends per Share - Common Stock Primary Issue 0 0 2.2 0 0
Diluted Normalized EPS 1.88895 2.02422 1.99396 2.32068 2.29612
Total Adjustments to Net Income 1 1 1
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 12201 10982 9280 9003 9236
Cash and Short Term Investments 2175 1685 1234 598 2199
Cash & Equivalents 1854 1511 1109 541 779
Short Term Investments 321 174 125 57 1420
Total Receivables, Net 4688 4345 3910 4233 3738
Accounts Receivable - Trade, Net 4242 3853 3390 3644 3278
Total Inventory 4632 3900 3294 3342 2764
Prepaid Expenses 570 519 493 435
Other Current Assets, Total 706 482 323 337 100
Total Assets 48535 45362 41796 43811 36888
Property/Plant/Equipment, Total - Net 8204 7217 6421 6213 4811
Property/Plant/Equipment, Total - Gross 14810 13228 12561 10551
Accumulated Depreciation, Total -7593 -6808 -6348 -5740
Goodwill, Net 18389 17004 15959 17141 13764
Intangibles, Net 7335 7612 7653 9175 7237
Long Term Investments 960 3 1
Note Receivable - Long Term 37 922 830 746 614
Other Long Term Assets, Total 1409 1622 1652 1533 1226
Total Current Liabilities 9514 10432 9231 11842 8517
Accounts Payable 2499 2380 1768 2054 1766
Accrued Expenses 81 1204 975 791 799
Notes Payable/Short Term Debt 0 0 200 205 113
Current Port. of LT Debt/Capital Leases 1198 2496 2095 4326 2086
Other Current Liabilities, Total 5736 4352 4193 4466 3753
Total Liabilities 22608 24024 24850 25945 19688
Total Long Term Debt 9200 8270 9745 8588 6608
Long Term Debt 9200 7928 9418 8130 6608
Deferred Income Tax 1287 1411 1441 1828 1288
Minority Interest 78 78 71 48 33
Other Liabilities, Total 2529 3833 4362 3639 3242
Total Equity 25927 21338 16946 17866 17200
Preferred Stock - Non Redeemable, Net 397 397 397 397
Common Stock 565 168 168 168 168
Additional Paid-In Capital 3814 3814 3814 3814 3814
Retained Earnings (Accumulated Deficit) 21549 16673 14556 13236 12532
Other Equity, Total -1 286 -1989 251 289
Total Liabilities & Shareholders’ Equity 48535 45362 41796 43811 36888
Total Common Shares Outstanding 434.778 434.778 434.778 434.778 434.778
Capital Lease Obligations 342 327 458
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 13566 13019 12951 12201 12943
Cash and Short Term Investments 2583 1927 1721 2175 1951
Cash & Equivalents 2365 1761 1584 1854 1604
Short Term Investments 218 166 137 321 347
Total Receivables, Net 4871 4846 4825 4688 4796
Accounts Receivable - Trade, Net 4317 4337 4403 4242 4483
Total Inventory 4971 4996 4890 4632 4860
Other Current Assets, Total 1141 1250 1515 706 1336
Total Assets 49906 48782 48637 48535 50933
Property/Plant/Equipment, Total - Net 8719 8393 8218 8204 7946
Goodwill, Net 18466 18102 18077 18389 19534
Intangibles, Net 6716 6765 6954 7335 8080
Long Term Investments 993 1044 962 960 965
Note Receivable - Long Term 33 32 33 37 37
Other Long Term Assets, Total 1413 1427 1442 1409 1428
Total Current Liabilities 8685 8846 9556 9514 9412
Accounts Payable 2244 2403 2326 2499 2445
Accrued Expenses 124 106 132 81 207
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 1402 1648 1436 1198 1754
Other Current Liabilities, Total 4915 4689 5662 5736 5006
Total Liabilities 21685 22081 22488 22608 22673
Total Long Term Debt 9540 9495 9159 9200 9266
Long Term Debt 9540 9495 9159 9200 9266
Deferred Income Tax 1134 1182 1219 1287 1449
Minority Interest 73 71 81 78 77
Other Liabilities, Total 2253 2487 2473 2529 2469
Total Equity 28221 26701 26149 25927 28260
Preferred Stock - Non Redeemable, Net
Common Stock 565 565 565 565 565
Additional Paid-In Capital 3814 3814 3814 3814 3814
Retained Earnings (Accumulated Deficit) 23843 22321 21770 21549 23881
Other Equity, Total -1 1 -1
Total Liabilities & Shareholders’ Equity 49906 48782 48637 48535 50933
Total Common Shares Outstanding 434.778 434.778 434.778 434.778 434.778
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 3339 3065 1994 1324 3396
Cash From Operating Activities 4259 4616 3477 2856 2219
Cash From Operating Activities 2030 1762 1938 1944 1812
Non-Cash Items -27 62 -59 149 -2523
Changes in Working Capital -1083 -273 -396 -561 -466
Cash From Investing Activities -2743 -1578 -1340 -6153 2191
Capital Expenditures -1806 -1421 -1563 -1021 -1016
Other Investing Cash Flow Items, Total -937 -157 223 -5132 3207
Cash From Financing Activities -1555 -2504 -1522 1902 -2825
Financing Cash Flow Items -728 -576 -519 -527 -607
Total Cash Dividends Paid -239 -181 -168 -162 -162
Issuance (Retirement) of Debt, Net -588 -1747 -835 2591 -2056
Foreign Exchange Effects -7 9 -40 5 -5
Net Change in Cash -46 543 575 -1390 1580
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line 800 3339 2680 1754 884
Cash From Operating Activities 853 4259 3244 1692 840
Cash From Operating Activities 456 2030 1432 962 430
Non-Cash Items 17 -27 -33 -24 -24
Changes in Working Capital -420 -1083 -835 -1000 -450
Cash From Investing Activities -1231 -2743 -2497 -1875 -1089
Capital Expenditures -651 -1806 -1274 -797 -498
Other Investing Cash Flow Items, Total -580 -937 -1223 -1078 -591
Cash From Financing Activities 124 -1555 -1057 -148 -315
Financing Cash Flow Items -91 -728 -728 -728 -100
Total Cash Dividends Paid 0 -239 -239 -239 0
Issuance (Retirement) of Debt, Net 215 -588 -90 819 -215
Foreign Exchange Effects -16 -7 15 11 4
Net Change in Cash -270 -46 -295 -320 -560
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
BlackRock Institutional Trust Company, N.A. Investment Advisor 7.2433 9361404 155118 2023-10-20 LOW
MFS Investment Management Investment Advisor/Hedge Fund 5.0579 6536955 0 2023-08-09 LOW
Amundi Asset Management, SAS Investment Advisor/Hedge Fund 3.028 3913494 0 2023-08-09 LOW
Fidelity Management & Research Company LLC Investment Advisor 3.0193 3902150 0 2023-08-09 LOW
DWS Investment GmbH Investment Advisor/Hedge Fund 2.9455 3806894 0 2023-08-09 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.91 3760974 5839 2023-09-30 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 2.3464 3032598 488031 2022-12-31 LOW
Deka Investment GmbH Investment Advisor/Hedge Fund 1.3785 1781591 -3317 2023-09-30 LOW
FMR Investment Management (U.K.) Limited Investment Advisor 1.1882 1535706 71669 2023-08-31 LOW
BlackRock Advisors (UK) Limited Investment Advisor/Hedge Fund 1.1525 1489463 14744 2023-09-30 LOW
Fidelity International Investment Advisor 1.0282 1328900 -1280 2023-09-30 LOW
Allianz Global Investors GmbH Investment Advisor 0.9738 1258572 -3752 2023-08-31 LOW
Union Investment Privatfonds GmbH Investment Advisor 0.9727 1257109 -9888 2023-06-30 LOW
BlackRock Investment Management (UK) Ltd. Investment Advisor/Hedge Fund 0.7247 936660 99 2023-09-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.6969 900656 429 2023-09-30 LOW
Walter Scott & Partners Ltd. Investment Advisor/Hedge Fund 0.6746 871928 0 2023-09-30 LOW
INVESCO Asset Management Limited Investment Advisor/Hedge Fund 0.6575 849754 18132 2023-08-31 LOW
Swedbank Robur Fonder AB Investment Advisor/Hedge Fund 0.6558 847606 0 2023-09-30 LOW
BlackRock Asset Management Deutschland AG Investment Advisor 0.649 838791 12302 2023-09-30 LOW
Lazard Asset Management, L.L.C. Investment Advisor/Hedge Fund 0.5731 740726 11 2023-09-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Merck - EUR Company profile

About Merck KGaA

Merck KGaA is a Germany-based science and technology company. The Company operates in three business segments: Healthcare, Life Sciences and Electronics. The Healthcare business, which operates in the United States and Canada as EMD Serono, focuses on such therapeutic areas as allergies, fertility, oncology and neurodegenerative diseases, developing drugs, diagnostic substances and medical devices. The Life Sciences business comprises the activities of MilliporeSigma, which provides solutions that facilitate biotechnology and pharmaceutical research. The product range includes laboratory water systems, gene editing tools, cell lines and end-to-end drug manufacturing systems, among others. The Electronics business enables digital living and provides specialty chemicals for various applications, including liquid crystals for electronic displays, materials for integrated circuits, effect pigments for coatings and color cosmetics, as well as functional materials for energy solutions.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Merck KGaA revenues increased 12% to EUR19.69B. Net income applicable to common stockholders increased 54% to EUR3.06B. Revenues reflect Life Science segment increase of 20% to EUR8.99B, Healthcare segment increase of 7% to EUR7.09B, United States (Country) segment increase of 13% to EUR5.25B, Rest of Europe segment increase of 14% to EUR4.03B.

Equity composition

2003 Q1 has been restated to reflect discontinued operations. 01/2007, Rights Issue, 4 new shares for every 29 shares held @ EUR 78 (Factor: 1.015602). 6/2014, 2-for-1 stock split (Factor: 2).

Industry: Proprietary & Advanced Pharmaceuticals

Frankfurter Str. 250
DARMSTADT
HESSEN 64293
DE

Income Statement

  • Annual
  • Quarterly

News

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

UK Bank Earnings: What to expect from Lloyds, Barclays and HSBC?

UK banks will be in the spotlight in the week ahead as the European earnings season continues

16:38, 16 February 2024

Is Big Tech behind the apparent bull market rally?

While the Magnificent Seven have dominated market momentum in recent months, it’s not true that they are the sole drivers of the recent rally in equity markets.

16:05, 8 February 2024

US Earnings Week Ahead: Walt Disney, Uber, and Pepsi Co.

The last of the Magnificent Seven have reported, delivering mixed results. Meanwhile, according to FactSet, the S&P 500 is set for negative earnings growth for Q4, with estimates for the next quarter also downgraded.

16:24, 2 February 2024

Bank of England preview: will updated projections show more cuts are expected in 2024?

Markets have no doubt that the BoE will keep its rate unchanged

15:43, 31 January 2024

Meta Platforms Q4 earnings forecast to surge on solid ad revenues

Meta Platforms (META) reports its Q4 results after Wall Street’s closing bell on February 1, 2024. We preview what to expect from the results and analyse the stock’s technicals.

15:33, 31 January 2024

Federal Reserve meeting preview: strong data is making it hard to justify cutting rates

Markets expect the Fed to keep rates unchanged as strong economic data continues

11:30, 30 January 2024

People also watch

Oil - Crude

77.27 Price
-1.220% 1D Chg, %
Long position overnight fee 0.0081%
Short position overnight fee -0.0300%
Overnight fee time 22:00 (UTC)
Spread 0.030

US100

17,505.40 Price
-1.230% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0039%
Overnight fee time 22:00 (UTC)
Spread 1.8

BTC/USD

51,935.60 Price
-0.050% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

Gold

2,030.83 Price
+0.630% 1D Chg, %
Long position overnight fee -0.0188%
Short position overnight fee 0.0106%
Overnight fee time 22:00 (UTC)
Spread 0.30

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading